BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 28917469)

  • 1. Prior authorizations for dermatologic medications: An American Academy of Dermatology survey of US dermatology providers and staff.
    Secrest AM; Asgari MM; Kourosh AS; Barbieri JS; Albrecht J;
    J Am Acad Dermatol; 2017 Oct; 77(4):784-786. PubMed ID: 28917469
    [No Abstract]   [Full Text] [Related]  

  • 2. The state and consequences of dermatology drug prices in the United States.
    Albrecht J; Lebwohl M; Asgari MM; Bennett DD; Cook A; Evans CC; Green LJ; Hodge JA; Kourosh AS; Maloney ME; Howard LM; Olsen EA; Rosenberg SP; Rubin A; Stough DB; Taylor SC; Brod BA
    J Am Acad Dermatol; 2016 Sep; 75(3):603-605. PubMed ID: 27423978
    [No Abstract]   [Full Text] [Related]  

  • 3. Understanding the cost of dermatologic care: A survey study of dermatology providers, residents, and patients.
    Steen AJ; Mann JA; Carlberg VM; Kimball AB; Musty MJ; Simpson EL
    J Am Acad Dermatol; 2017 Apr; 76(4):609-617. PubMed ID: 28189269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissecting drug pricing: Supply chain, market, and nonmarket trends impacting clinical dermatology.
    Nguyen HP; Go JA; Barbieri JS; Stough D; Stoff BK; Forman HP; Bolognia JL; Albrecht J;
    J Am Acad Dermatol; 2020 Aug; 83(2):691-699. PubMed ID: 32330637
    [No Abstract]   [Full Text] [Related]  

  • 5. The American Academy of Dermatology should not endorse product sales from physicians' offices.
    Lombardo PC
    Arch Dermatol; 1999 Aug; 135(8):995. PubMed ID: 10456361
    [No Abstract]   [Full Text] [Related]  

  • 6. [Intermittent treatment regimens and the rational (efficient) use of biologic agents in psoriasis].
    Moreno-Ramírez D
    Actas Dermosifiliogr; 2011 May; 102(4):241-3. PubMed ID: 21481332
    [No Abstract]   [Full Text] [Related]  

  • 7. Administrative Burden and Costs of Prior Authorizations in a Dermatology Department.
    Carlisle RP; Flint ND; Hopkins ZH; Eliason MJ; Duffin KC; Secrest AM
    JAMA Dermatol; 2020 Oct; 156(10):1074-1078. PubMed ID: 32845288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medicare Part D payments for brand and generic drugs prescribed by dermatologists.
    Powell HB; Adamson AS
    J Am Acad Dermatol; 2018 Sep; 79(3):575-577. PubMed ID: 29477736
    [No Abstract]   [Full Text] [Related]  

  • 9. Information system technologies' role in augmenting dermatologists' knowledge of prescription medication costs.
    DeMarco SS; Paul R; Kilpatrick RJ
    Int J Med Inform; 2015 Dec; 84(12):1076-84. PubMed ID: 26228652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic stewardship in acne management.
    Rosamilia LL
    Cutis; 2018 Jul; 102(1):8-9. PubMed ID: 30138500
    [No Abstract]   [Full Text] [Related]  

  • 11. Commentary: unapproved uses, dosages, or indications in dermatology: a physician's reference.
    Wolf R
    Clin Dermatol; 2002; 20(5):465-6. PubMed ID: 12435515
    [No Abstract]   [Full Text] [Related]  

  • 12. Generic drugs in dermatology: part I.
    Payette M; Grant-Kels JM
    J Am Acad Dermatol; 2012 Mar; 66(3):343.e1-8; quiz 351-2. PubMed ID: 22342021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generic drugs in dermatology: part II.
    Payette M; Grant-Kels JM
    J Am Acad Dermatol; 2012 Mar; 66(3):353.e1-15; quiz 367-8. PubMed ID: 22342022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Regress for expensive medicines? When costly therapies are not a problem].
    Nitz G
    MMW Fortschr Med; 2013 Feb; 155(3):12. PubMed ID: 23573755
    [No Abstract]   [Full Text] [Related]  

  • 15. Management of hidradenitis suppurativa: a U.K. survey of current practice.
    Ingram JR; McPhee M
    Br J Dermatol; 2015 Oct; 173(4):1070-2. PubMed ID: 25913663
    [No Abstract]   [Full Text] [Related]  

  • 16. A cross-sectional survey of knowledge, attitudes, and practice in the prescription of isotretinoin for transgender patients among academic dermatologists.
    Ensslin CJ; Khanijow K; Yenokyan G; Loss M
    J Am Acad Dermatol; 2019 Dec; 81(6):1426-1429. PubMed ID: 31648856
    [No Abstract]   [Full Text] [Related]  

  • 17. Brand name versus generic drugs: the ethical quandary in caring for our sophisticated patients while trying to reduce health-care costs: facts and controversies.
    Payette M; Grant-Kels JM
    Clin Dermatol; 2013; 31(6):772-6. PubMed ID: 24160285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dermatologists should guard their patients' purse, not pick their pockets!
    Miller RC
    Arch Dermatol; 1999 Mar; 135(3):255-6. PubMed ID: 10086444
    [No Abstract]   [Full Text] [Related]  

  • 19. The legal status of patient-delivered partner therapy for sexually transmitted infections in the United States: a national survey of state medical and pharmacy boards.
    Golden MR; Anukam U; Williams DH; Handsfield HH
    Sex Transm Dis; 2005 Feb; 32(2):112-4. PubMed ID: 15668618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Appropriate off-label prescription in practice].
    Augustin M
    Hautarzt; 2013 Oct; 64(10):728-35. PubMed ID: 24150820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.